Bayer Reaches $2 Bln Deal Over Future Roundup Cancer Claims
Bayer struck a $2 billion deal to resolve a class action of future claims relating to allegations that its widely used weedkiller Roundup causes cancer, the company and lawyers for US consumers said on Wednesday. Reuters Health Information